Enduring Materials

 

ORDER COMPLIMENTARY CME ENDURING MATERIALS

 

 

 

botulinumguide

This educational activity is jointly sponsored by the University of
California, Irvine and the Neurotoxin Institute.

 

schoolofmedicine

 

neurotoxininstitute

 

Supported by an unrestricted educational grant from Allergan, Inc.

allergan

A Multispecialty Guide to the Use of BOTULINUM NEUROTOXINS
(166 -page booklet)

 

Editors:
Mark Hallett, MD
Joseph Jankovic, MD
Stephen D. Silberstein, MD, FACP


Advisory Editors:
Alberto Esquenazi, MD
Michael B. Chancellor, MD
Supreet Deshpande, MD
F. Michael Ferrante, MD
Mark E. Gormley, Jr, MD
Pankaj J. Pasricha, MD

 

After completing this CME Activity, participants should be able to:

  • Understand the conceptual basis and mechanism of action underlying the therapeutic application of BoNTs in a broad array of clinical conditions.
  • Review a range of clinical applications in which BoNT has been shown to have some effect.
  • Identify appropriate patients for therapy and determine condition-specific techniques, including injection-site selection and dosing of BoNT.
  • Discuss procedures for administering BoNT therapy.

Expiration Date:  December 31, 2010

Method of participation: Please note that the accreditation period for this material has expired. You may still order this handbook for reference purposes, but no CME credits can be earned.

orderbutton

 

 

 


 

oneup

This educational activity is jointly sponsored by
Beth Israel Medical Center & Scientiae, LLC.

 

bethisrael

 

scientiae

 

Supported by an unrestricted educational grant from Allergan, Inc.

allergan

O.N.E. U.P.
(Optimizing Neurotoxin Efficacy Utilizing Physical and Occupational Therapy)


Adult Upper Motor Neuron Syndrome/Adult Spasticity

Package contains:

For the Physical Therapist: 1 Physician/Therapist AMA PRA certified DVD
For Your Patients: 5 Patient Companion Booklets; 10 Home Exercise Program DVDs


Chair:
Cindy B. Invanhoe, MD

 

Faculty:
Atul T. Patel, MD
Heather Horak, PT
Rene Peré, OTR

 

Course Director:
Susan Bressman, MD

Original Release Date: April 15, 2009

Expiration Date: April 15, 2011

Method of Participation: Please note that the accreditation period for this material has expired. You may still order this handbook for reference purposes, but no CME credits can be earned.


Target Audience: The goal of this program is to educate healthcare providers who manage patients with upper motor neuron syndrome/spasticity including, but not limited to, Neurologists, Physiatrists, Physical Therapists and Occupational Therapists.

Needs Assessment: The purpose of this enduring material activity is to explain how patient outcomes can be improved in many cases with adjunctive physical and occupational therapy. There is lack of awareness among botulinum neurotoxin injectors concerning the added benefit of physical therapy and occupational therapy as follow-up to injection therapy for Upper Motor Neuron Syndrome/Adult Spasticity. Physicians, physical therapists and occupational therapists will be able to provide their patients with the accompanying DVD and printed materials. Please register to request these materials.

After completing this CME Activity, participants should be able to:

  • Assess patients with Adult Upper Motor Neuron Syndrome/Adult Spasticity to identify appropriate candidates for adjunctive physical/occupational therapy post-neurotoxin injection.
  • Recognize the importance of adjunctive physical/occupational therapy for Adult Upper Motor Neuron Syndrome/Adult Spasticity patients treated with BoNT for improved patient care.
  • Recall standardized physical/occupational therapy protocols to optimize patient outcome.
  • Instruct their patients on home exercise and home activity programs to provide the comprehensive follow-up needed in these cases.

Faculty Disclosure Policy: It is the policy of Beth Israel Medical Center & St. Luke’s and Roosevelt Hospitals that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Beth Israel Medical Center & St. Luke’s and Roosevelt Hospitals have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure information is contained in the course handout materials.

 

orderbutton

 

 

 


 

oneup

 

Please Note: Due to warehouse damage as a result of Hurricane Sandy in October 2012, this item is out of stock

Botulinum Toxin: Therapeutic Clinical Practice & Science, (textbook), 512 pages, published 2009 by Saunders/Elsevier


Joseph Jankovic, MD; Alberto Albanese, MD; M. Zouhair Atassi, PhD, DSc; J. Oliver Dolly, MSc, PhD, DSc; Mark Hallett, MD; and Nathaniel H. Mayer, MD

 

Description:
The new, therapeutically focused Botulinum Toxin presents comprehensive, cross-disciplinary guidance on current practices, covering more than 100 non-cosmetic conditions that occur in neurology, physical medicine and rehabilitation, pain medicine, ophthalmology, gastroenterology, urology, orthopedics and surgery.  With discussions of the latest in approved treatments as well as new and emerging uses, you’ll get in-depth management guidance on the application of the toxin

  • Covers a broad array of hot topics, including botulinum toxin for the treatment of cranial-cervical dystonias, motor disorders in cerebral palsy, bruxism and temporomandibular disorders, headache, overactive bladder, chronic pelvic pain syndrome, arthritis joint pain, and wound healing.
  • Focuses on approved uses, but also discusses new and emerging applications to expose you to additional treatment options.
  • Offers cross-disciplinary guidance from an authoritative, international group of authors who demonstrate the applications of botulinum toxin across various specialties.
  • Presents the most comprehensive and up-to-date material available so you get all the information you need from this one resource

 

orderbutton

 

Subscribe to our newsletter